Skip to content
  • Saturday, 15 August 2026
  • 12:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Lifelong Mental Stimulation Linked to Significant Delay in Alzheimer’s Disease Onset and Slower Cognitive Decline
Neuroscience & Brain Research

Lifelong Mental Stimulation Linked to Significant Delay in Alzheimer’s Disease Onset and Slower Cognitive Decline

Rifan Muazin May 16, 2026 0

Engaging in a consistent regimen of mentally stimulating activities throughout one’s life, such as reading, writing, and the acquisition of…

Read More
Neuroscience & Brain Research

Lifelong Mental Stimulation Linked to Delayed Alzheimer’s Onset and Slower Cognitive Decline

Rifan Muazin May 8, 2026 0

A comprehensive longitudinal study published in Neurology, the medical journal of the American Academy of Neurology, suggests that maintaining a…

Read More
Finnish Researchers Achieve Unprecedented Sensitivity in Quantum Energy Detection Breaking the Zeptojoule BarrierFrom Coal to Clean Energy Cumberland Explores the Geothermal Potential of Its Abandoned Mine NetworksNavigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial SuccessScience News: A Century of Empowering Public Understanding of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ